Viable podocyturia in healthy individuals: implications for podocytopathies - PubMed (original) (raw)

Viable podocyturia in healthy individuals: implications for podocytopathies

Silvia Maestroni et al. Am J Kidney Dis. 2014 Dec.

No abstract available

PubMed Disclaimer

Similar articles

• Acute and transient podocyte loss and proteinuria in preeclampsia.
  Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, Suzuki T, Hara M, Nagata M. Aita K, et al. Nephron Clin Pract. 2009;112(2):c65-70. doi: 10.1159/000213083. Epub 2009 Apr 18. Nephron Clin Pract. 2009. PMID: 19390204
• Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity.
  Petermann A, Floege J. Petermann A, et al. Nephron Clin Pract. 2007;106(2):c61-6. doi: 10.1159/000101799. Epub 2007 Jun 6. Nephron Clin Pract. 2007. PMID: 17570931 Review.
• Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies.
  Hayman SR, Calle JC, Jatoi A, Craici IM, Wagner SJ, Weaver AL, Greene EL, Grande JP, Garovic VD. Hayman SR, et al. Oncology. 2014;86(5-6):271-8. doi: 10.1159/000360180. Epub 2014 Jun 4. Oncology. 2014. PMID: 24902997
• Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
  Lee HS, Song CY. Lee HS, et al. Kidney Blood Press Res. 2010;33(1):24-9. doi: 10.1159/000285844. Epub 2010 Feb 23. Kidney Blood Press Res. 2010. PMID: 20185928 Review.
• The role of podocytes in proteinuria.
  Asanuma K, Yanagida-Asanuma E, Takagi M, Kodama F, Tomino Y. Asanuma K, et al. Nephrology (Carlton). 2007 Dec;12 Suppl 3:S15-20. doi: 10.1111/j.1440-1797.2007.00876.x. Nephrology (Carlton). 2007. PMID: 17995522 Review.

Cited by

• Podocyturia in Fabry disease: a 10-year follow-up.
  Vujkovac B, Srebotnik Kirbiš I, Keber T, Cokan Vujkovac A, Tretjak M, Radoš Krnel S. Vujkovac B, et al. Clin Kidney J. 2021 Sep 16;15(2):269-277. doi: 10.1093/ckj/sfab172. eCollection 2022 Feb. Clin Kidney J. 2021. PMID: 35145641 Free PMC article.
• In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
  Trimarchi H, Paulero M, Canzonieri R, Schiel A, Iotti A, Costales-Collaguazo C, Stern A, Forrester M, Lombi F, Pomeranz V, Iriarte R, Rengel T, Gonzalez-Hoyos I, Muryan A, Zotta E. Trimarchi H, et al. Case Rep Nephrol. 2017;2017:1292531. doi: 10.1155/2017/1292531. Epub 2017 Apr 3. Case Rep Nephrol. 2017. PMID: 28473934 Free PMC article.
• In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia.
  Trimarchi H, Canzonieri R, Schiel A, Costales-Collaguazo C, Stern A, Paulero M, Rengel T, Andrews J, Iotti A, Forrester M, Lombi F, Pomeranz V, Iriarte R, Muryan A, Zotta E. Trimarchi H, et al. Nephron Extra. 2017 May 16;7(2):52-61. doi: 10.1159/000473888. eCollection 2017 May-Aug. Nephron Extra. 2017. PMID: 28626472 Free PMC article.
• Podocyturia: Potential applications and current limitations.
  Trimarchi H. Trimarchi H. World J Nephrol. 2017 Sep 6;6(5):221-228. doi: 10.5527/wjn.v6.i5.221. World J Nephrol. 2017. PMID: 28948159 Free PMC article. Review.
• Mechanisms of Podocyte Detachment, Podocyturia, and Risk of Progression of Glomerulopathies.
  Trimarchi H. Trimarchi H. Kidney Dis (Basel). 2020 Sep;6(5):324-329. doi: 10.1159/000507997. Epub 2020 May 27. Kidney Dis (Basel). 2020. PMID: 33490112 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations